Supplemental Agreement No. 18 to Purchase Agreement No. 2910 between THE BOEING COMPANY and GAC Inc. Relating to Boeing Model 737-8EH Aircraft
Supplemental Agreement No. 18
to
Purchase Agreement No. 2910
between
THE BOEING COMPANY
and
GAC Inc.
Relating to Boeing Model 737-8EH Aircraft
THIS SUPPLEMENTAL AGREEMENT, entered into as of the _________ day of ____________________ 2010, by and between THE BOEING COMPANY, a Delaware corporation with its principal offices in the City of Seattle, State of Washington, USA (Boeing), and GAC Inc. (Buyer), a company organized under the laws of the Cayman Islands (Buyer);
W I T N E S S E T H:
WHEREAS, Boeing and Buyer entered into Purchase Agreement No. 2910, dated 17 May 2004, as amended and supplemented (the Agreement) relating to the purchase and sale of fifteen (15) Boeing Model 737-8EH aircraft; and
Whereas, Buyer and Boeing now wish to amend certain terms and conditions associated with the Agreement, and
WHEREAS, Boeing and Buyer have agreed to amend the Agreement to incorporate Buyer’s decision to exercise its right of aircraft substitution and change the Table 4 model 737-800 [CONFIDENTIAL PORTION OMITTED AND FILED SEPARATELY WITH THE COMMISSION PURSUANT TO A REQUEST FOR CONFIDENTIAL TREATMENT] and the Table [CONFIDENTIAL PORTION OMITTED AND FILED SEPARATELY WITH THE COMMISSION PURSUANT TO A REQUEST FOR CONFIDENTIAL TREATMENT] model 737-800 delivery [CONFIDENTIAL PORTION OMITTED AND FILED SEPARATELY WITH THE COMMISSION PURSUANT TO A REQUEST FOR CONFIDENTIAL TREATMENT] to both now become model 737-700 aircraft, and
WHEREAS, Boeing and Buyer have also agreed to amend the Agreement to incorporate certain other changes as may be described herein;
NOW, THEREFORE, in consideration of the mutual covenants contained herein, the parties agree to amend the Agreement as follows:
1
1. Table of Contents.
Remove and replace, in its entirety, the Table of Contents with a new Table of Contents (attached hereto) to reflect the incorporation of this Supplemental Agreement No. 18 (SA-18) into the Purchase Agreement.
2. Tables.
Per the terms and conditions of our mutually agreed upon Letter Agreement No. 6-1162-DME-1106R1, Aircraft Model Substitution, (i) Buyer has taken the decision to change the Table 4 model 737-800[CONFIDENTIAL PORTION OMITTED AND FILED SEPARATELY WITH THE COMMISSION PURSUANT TO A REQUEST FOR CONFIDENTIAL TREATMENT] to both now become model 737-700 aircraft, and (ii) [CONFIDENTIAL PORTION OMITTED AND FILED SEPARATELY WITH THE COMMISSION PURSUANT TO A REQUEST FOR CONFIDENTIAL TREATMENT]
2.1 Remove and replace Table 4, Aircraft Delivery, Description, Price and Advance Payments, with the new Table 4 (attached hereto) to incorporate the deletion of the model 737-800 [CONFIDENTIAL PORTION OMITTED AND FILED SEPARATELY WITH THE COMMISSION PURSUANT TO A REQUEST FOR CONFIDENTIAL TREATMENT].
2.2 Add the new Table 12, Aircraft Delivery, Description, Price and Advance Payments, with the new Table 2 (attached hereto) in order to incorporate the addition of the model 737-700 [CONFIDENTIAL PORTION OMITTED AND FILED SEPARATELY WITH THE COMMISSION PURSUANT TO A REQUEST FOR CONFIDENTIAL TREATMENT].
3. Exhibits.
Add the new Exhibit A6, Baseline 737-700 Aircraft Configuratiion – Table 12 [CONFIDENTIAL PORTION OMITTED AND FILED SEPARATELY WITH THE COMMISSION PURSUANT TO A REQUEST FOR CONFIDENTIAL TREATMENT], to the Purchase Agreement in order to provide the current detail configuration elements and prices that are applicable to the Table 12 aircraft.
4. Letter Agreements.
4.1 Add the new Letter Agreement No. 6-1162-DME-1213, Special Matters – Table 12 Aircraft, (attached hereto) in order to capture and incorporate the special business considerations pertaining to the Table 12 Aircraft.
4.2 Remove and replace page 1 and page 2 of Letter Agreement No.
6-1162-DME-0825, Market Risk – Escalation, with a new Page 1 and Page 2 (attached hereto), and also add the new Attachment C, (attached hereto) in order to include the Table 12 model 737-700 aircraft that [CONFIDENTIAL PORTION OMITTED AND FILED SEPARATELY WITH THE COMMISSION PURSUANT TO A REQUEST FOR CONFIDENTIAL TREATMENT].
4.3 Remove and replace page 2 of Letter Agreement No. 6-1162-DME-1107,
2 Promotional Support Agreement – Varig, (attached hereto) in order to extend the performance period to 30 June 2011.
4.4 Remove and replace page 2 and page 3 of Letter Agreement No.
6-1162-DME-0824R2, Special Matters – Table 1 through Table 7 Aircraft, (attached hereto) in order to further clarify the time period for use of the described funds.
3
5. Confidential Treatment.
Customer and Boeing each understands that certain commercial and financial information contained in this Business Offer are considered by both Customer and Boeing as confidential. Customer and Boeing agree that each will treat this Business Offer and the information contained herein as confidential and, except as otherwise required by law, will not, without the prior written consent of the other party, disclose this Business Offer or any information contained herein to any other person or entity.
________________________________________
The Purchase Agreement, Exhibits and Letter Agreements shall be deemed amended to the extent herein provided and as so amended shall continue in full force and effect. In the event of any inconsistency between the above provisions and those provisions contained in the Purchase Agreement, the terms of this Supplemental Agreement will govern and control.
EXECUTED IN DUPLICATE as of the day and year first above written.
THE BOEING COMPANY
By _________________________
Its Attorney‑In‑Fact
GAC INC.
By _________________________
Its
4
TABLE OF CONTENTS
SUPPLEMENTAL | |||
AGREEMENT | |||
NUMBER | |||
ARTICLES | |||
1. | Quantity, Model and Description | ||
2. | Delivery Schedule | ||
3. | Price | ||
4. | Payment | ||
5. | Miscellaneous | ||
TABLE | |||
1. | Aircraft Information Table 1 (Block 1 aircraft) | SA-13 | |
2. | Aircraft Information Table 2 (Block 2 aircraft) | SA-16 | |
3. | Aircraft Information Table 3 (Block 3 aircraft) | SA-11 | |
4. | Aircraft Information Table 4 (Block 4 aircraft) | SA-18 | |
5. | Aircraft Information Table 5 (Block 5 aircraft) | SA-15 | |
6. | Aircraft Information Table 6 (Block 6 aircraft) | SA-13 | |
7. | Aircraft Information Table 7 (Block 7 aircraft) | SA-14 | |
8. | Aircraft Information Table 8 (Block 8 aircraft) | SA-16 | |
9. | Aircraft Information Table 9 (Block 9 aircraft) | SA-17 | |
10. | Aircraft Information Table 00 (Xxxxx 00 xxxxxxxx) | XX-00 | |
00. | Aircraft Information Table 00 (Xxxxx 00 xxxxxxxx) | XX-00 | |
00. | Aircraft Information Table 12 (Block 12 aircraft) | SA-18 | |
EXHIBIT | |||
A. | A1. | Aircraft Configuration Table 1-4 (737-800) | XX-0 |
X0. | Aircraft Configuration (737-800 w/ O/H stowage) | SA-10 | |
A3. | Aircraft Configuration – Table 7 (737-700) | SA-14 | |
A4. | Aircraft Configuration – Table 5-6 (737-800) | SA-15 | |
A5. | Aircraft Configuration – Table 8-11 (737-800) | SA-15 | |
A6. | Baseline 737-700 Aircraft Configuration – Table 12 | SA-18 | |
B. | Aircraft Delivery Requirements and Responsibilities | ||
SUPPLEMENTAL EXHIBITS | |||
AE1. | Escalation Adjustment/Airframe and Optional Features | SA-5 | |
BFE1. | BFE Variables | SA-17 | |
CS1. | Customer Support Variables | ||
EE1. | Engine Escalation/Engine Warranty and Patent Indemnity | ||
SLP1. | Service Life Policy Components |
i
SUPPLEMENTAL | ||
LETTER AGREEMENTS | AGREEMENT | |
NUMBER | ||
2910-01 | Customer Software | |
2910-02 | Spares – Flight Crew Training Spare Parts Support | |
2910-03 | Spares – Initial Provisioning | |
6-1162-DME-0706R4 | Purchase Rights | SA-15 |
6-1162-DME-0707R1 | Advance Payment Matters | SA-15 |
6-1162-DME-0708 | Technical Matters | |
6-1162-DME-0710 | Performance Guarantees (YK721-YK769) | SA-10 |
6-1162-DME-0711 | [CONFIDENTIAL PORTION OMITTED AND FILED SEPARATELY WITH THE COMMISSION PURSUANT TO A REQUEST FOR CONFIDENTIAL TREATMENT] | |
6-1162-DME-0712 | Special Matters (canceled & superseded) | SA-5 |
6-1162-DME-0713 | Tailored Weight Program | |
6-1162-DME-0714 | Demonstration Flight Waiver | |
6-1162-DME-0824R2 | Special Matters - Table 0-0 Xxxxxxxx | XX-00 |
0-0000-XXX-0000 | Xxxxxx Risk - Escalation | SA-18 |
6-1162-DME-0841 | [CONFIDENTIAL PORTION OMITTED AND FILED SEPARATELY WITH THE COMMISSION PURSUANT TO A REQUEST FOR CONFIDENTIAL TREATMENT] | SA-7 |
6-1162-DME-0867 | [CONFIDENTIAL PORTION OMITTED AND FILED SEPARATELY WITH THE COMMISSION PURSUANT TO A REQUEST FOR CONFIDENTIAL TREATMENT] | SA-7 |
6-1162- DME-1104 | [CONFIDENTIAL PORTION OMITTED AND FILED SEPARATELY WITH THE COMMISSION PURSUANT TO A REQUEST FOR CONFIDENTIAL TREATMENT] | SA-16 |
6-1162- DME-1106R1 | [CONFIDENTIAL PORTION OMITTED AND FILED SEPARATELY WITH THE COMMISSION PURSUANT TO A REQUEST FOR CONFIDENTIAL TREATMENT] | SA-15 |
6-1162- DME-1107 | [CONFIDENTIAL PORTION OMITTED AND FILED SEPARATELY WITH THE COMMISSION PURSUANT TO A REQUEST FOR CONFIDENTIAL TREATMENT] | SA-18 |
6-1162-DME-1111R1 | [CONFIDENTIAL PORTION OMITTED AND FILED SEPARATELY WITH THE COMMISSION PURSUANT TO A REQUEST FOR CONFIDENTIAL TREATMENT] | SA-14 |
6-1162- DME-1152 | [CONFIDENTIAL PORTION OMITTED AND FILED SEPARATELY WITH THE COMMISSION PURSUANT TO A REQUEST FOR CONFIDENTIAL TREATMENT] | |
6-1162- DME-1153 | [CONFIDENTIAL PORTION OMITTED AND FILED SEPARATELY WITH THE COMMISSION PURSUANT TO A REQUEST FOR CONFIDENTIAL TREATMENT] | SA-15 |
6-1162- DME-1162 | Special Matters – Table 8-11 Aircraft | SA-15 |
6-1162- DME-1164 | [CONFIDENTIAL PORTION OMITTED AND FILED SEPARATELY WITH THE COMMISSION PURSUANT TO A REQUEST FOR CONFIDENTIAL TREATMENT] | |
6-1162- DME-1185 | [CONFIDENTIAL PORTION OMITTED AND FILED SEPARATELY WITH THE COMMISSION PURSUANT TO A REQUEST FOR CONFIDENTIAL TREATMENT] | SA-16 |
6-1162- DME-1213 | Special Matters – Table 12 Aircraft | SA-18 |
ii
RECORD OF SUPPLEMENTAL AGREEMENTS | |||
SA-1 | 16 | July | 2004 |
SA-2 | 20 | January | 2005 |
SA-3 | 07 | March | 2005 |
XX-0 | 00 | Xxxxx | 0000 |
SA-5 | 25 | July | 2005 |
SA-6 | 26 | August | 2005 |
SA-7 | 18 | November | 2005 |
SA-8 | 17 | February | 2006 |
XX-0 | 00 | Xxxxx | 0000 |
SA-10 | 19 | October | 2006 |
SA-11 | 24 | October | 2006 |
SA-12 | 28 | February | 2007 |
SA-13 | 17 | December | 2007 |
SA-14 | 29 | September | 2008 |
SA-15 | 30 | April | 2009 |
SA-16 | 24 | September | 2009 |
SA-17 | 28 | October | 2009 |
SA-18 | __ | __________ | 2010 |
iii
Supplemental Agreement No. SA-18
Table 4 to Purchase Agreement No. 2910
Aircraft Delivery, Description, Price and Advance Payments
Airframe Model/MTOW: | 737-800 | Detail Specification: |
Engine Model/Thrust: | CFM56-7B27/B1 | Airframe Price Base Year/Escalation Formula: |
Airframe Price: | Engine Price Base Year/Escalation Formula: | |
Optional Features: | ||
Sub-Total of Airframe and Features: | Airframe Escalation Data: | |
Engine Price (Per Aircraft): | Base Year Index (ECI): | |
Aircraft Basic Price (Excluding BFE/SPE): | Base Year Index (CPI): | |
Buyer Furnished Equipment (BFE) Estimate: | ||
Seller Purchased Equipment (SPE) Estimate: |
Delivery Date |
Number of Aircraft |
Escalation Factor (Airframe) |
Escalation Estimate Adv Payment Base Price Per A/P |
Advance Payment Per Aircraft (Amts. Due/Mos. Prior to Delivery): | ||||||
Page 1
SA-18
Supplemental Agreement No. SA-18
Table 12 to Purchase Agreement No. PA-2910
Aircraft Delivery, Description, Price and Advance Payments
Airframe Model/MTOW: | 737-700 | Detail Specification: |
Engine Model/Thrust: | CFM56-7B22 | Airframe Price Base Year/Escalation Formula: |
Airframe Price: | Engine Price Base Year/Escalation Formula: | |
Optional Features: | ||
Sub-Total of Airframe and Features: | Airframe Escalation Data: | |
Engine Price (Per Aircraft): | Base Year Index (ECI): | |
Aircraft Basic Price (Excluding BFE/SPE): | Base Year Index (CPI): | |
Buyer Furnished Equipment (BFE) Estimate: | ||
Seller Purchased Equipment (SPE) Estimate: |
Delivery Date |
Number of Aircraft |
Escalation Factor (Airframe) |
Escalation Estimate Adv Payment Base Price Per A/P |
Advance Payment Per Aircraft (Amts. Due/Mos. Prior to Delivery): | ||||||
Page 1
Baseline Model 737-700 Aircraft | [CONFIDENTIAL PORTION OMITTED AND FILED SEPARATELY WITH THE COMMISSION PURSUANT TO A REQUEST FOR CONFIDENTIAL TREATMENT] | |
Exhibit A6 to Purchase Agreement No. 2910 | Price | |
CR | Title | Per A/C |
[CONFIDENTIAL PORTION OMITTED AND FILED SEPARATELY WITH THE COMMISSION PURSUANT TO A REQUEST FOR CONFIDENTIAL TREATMENT] |
Page 1
Baseline Model 737-700 Aircraft | [CONFIDENTIAL PORTION OMITTED AND FILED SEPARATELY WITH THE COMMISSION PURSUANT TO A REQUEST FOR CONFIDENTIAL TREATMENT] | |
Exhibit A6 to Purchase Agreement No. 2910 | Price | |
CR | Title | Per A/C |
[CONFIDENTIAL PORTION OMITTED AND FILED SEPARATELY WITH THE COMMISSION PURSUANT TO A REQUEST FOR CONFIDENTIAL TREATMENT] |
Page 2
Baseline Model 737-700 Aircraft | [CONFIDENTIAL PORTION OMITTED AND FILED SEPARATELY WITH THE COMMISSION PURSUANT TO A REQUEST FOR CONFIDENTIAL TREATMENT] | |
Exhibit A6 to Purchase Agreement No. 2910 | Price | |
CR | Title | Per A/C |
[CONFIDENTIAL PORTION OMITTED AND FILED SEPARATELY WITH THE COMMISSION PURSUANT TO A REQUEST FOR CONFIDENTIAL TREATMENT] |
Page 3
Baseline Model 737-700 Aircraft | [CONFIDENTIAL PORTION OMITTED AND FILED SEPARATELY WITH THE COMMISSION PURSUANT TO A REQUEST FOR CONFIDENTIAL TREATMENT] | |
Exhibit A6 to Purchase Agreement No. 2910 | Price | |
CR | Title | Per A/C |
[CONFIDENTIAL PORTION OMITTED AND FILED SEPARATELY WITH THE COMMISSION PURSUANT TO A REQUEST FOR CONFIDENTIAL TREATMENT] |
Page 4
Page 1
6-1162-DME-1213
GAC, Inc.
Praça Comandante Linneu Xxxxx s/n
Portaria 3
Prédio 7 Jardim Aeroporto
04626-020 São Paulo - SP Brazil
Subject: Special Matters – Table 12 Aircraft
Reference: Purchase Agreement No. 2910 (the Purchase Agreement) between The Boeing Company (Boeing) and GAC Inc. (Customer) relating to Model 737-7EH aircraft (Aircraft)
This letter agreement (Letter Agreement) amends and supplements the Purchase Agreement, and reflects the mutual agreement of the parties concerning certain business considerations pertaining to the Table 12 model 737-700 Aircraft, formerly Table 4 model 737-800 Aircraft. All below described business considerations that [CONFIDENTIAL PORTION OMITTED AND FILED SEPARATELY WITH THE COMMISSION PURSUANT TO A REQUEST FOR CONFIDENTIAL TREATMENT] are each limited to the terms and conditions described in Letter Agreement No. 6-1162-DME-0825 and 6-1162-DME-1104 as each may apply to specific aircraft. All terms used but not defined in this Letter Agreement have the same meaning as in the Purchase Agreement.
1. [CONFIDENTIAL PORTION OMITTED AND FILED SEPARATELY WITH THE COMMISSION PURSUANT TO A REQUEST FOR CONFIDENTIAL TREATMENT]
9. Confidential Treatment
Customer and Boeing each understands that certain commercial and financial information contained in this Letter Agreement are considered by both Customer and Boeing as confidential. Customer and Boeing agree that each will treat this Letter Agreement and the information contained herein as confidential and, except as otherwise required by law, will not, without the prior written consent of the other party, disclose this Letter Agreement or any information contained herein to any other person or entity.
Page 2
If the foregoing correctly sets forth your understanding of our agreement with respect to the matters treated above, please indicate your acceptance and approval below.
Very truly yours,
THE BOEING COMPANY
By
Its Attorney‑In‑Fact
ACCEPTED AND AGREED TO this
Date: , 2010
GAC INC.
By
Its
Page 1
6-1162-DME-0825
GAC, Inc..
Praça Comandante Linneu Xxxxx s/n
Portaria 3,
Prédio 7 Jardim Xxxxxxxxx
00000-000 Xxx Xxxxx – SP Brazil
Subject: Market Risk - Escalation
Reference: Purchase Agreement No. 2910 (the Purchase Agreement) between The Boeing Company (Boeing) and GAC Inc. (Customer) relating to Model 737-8EH aircraft (the Aircraft)
This letter agreement (Letter Agreement) amends and supplements the Purchase Agreement. All terms used but not defined in this Letter Agreement have the same meaning as in the Purchase Agreement.
[CONFIDENTIAL PORTION OMITTED AND FILED SEPARATELY WITH THE COMMISSION PURSUANT TO A REQUEST FOR CONFIDENTIAL TREATMENT]
1. [CONFIDENTIAL PORTION OMITTED AND FILED SEPARATELY WITH THE COMMISSION PURSUANT TO A REQUEST FOR CONFIDENTIAL TREATMENT]
1.1 Table 1 and Table 2 Aircraft
[CONFIDENTIAL PORTION OMITTED AND FILED SEPARATELY WITH THE COMMISSION PURSUANT TO A REQUEST FOR CONFIDENTIAL TREATMENT]
1.2 Table 3, Table 4, Table 7 and Table 12 Aircraft
[CONFIDENTIAL PORTION OMITTED AND FILED SEPARATELY WITH THE COMMISSION PURSUANT TO A REQUEST FOR CONFIDENTIAL TREATMENT]
2. [CONFIDENTIAL PORTION OMITTED AND FILED SEPARATELY WITH THE COMMISSION PURSUANT TO A REQUEST FOR CONFIDENTIAL TREATMENT]
[CONFIDENTIAL PORTION OMITTED AND FILED SEPARATELY WITH THE COMMISSION PURSUANT TO A REQUEST FOR CONFIDENTIAL TREATMENT]
3. Assignment
[CONFIDENTIAL PORTION OMITTED AND FILED SEPARATELY WITH THE COMMISSION PURSUANT TO A REQUEST FOR CONFIDENTIAL TREATMENT]
Page 2
4. Confidential Treatment
Customer and Boeing each understands that certain commercial and financial information contained in this Letter Agreement and any attachment(s) hereto are considered by
[CONFIDENTIAL PORTION OMITTED AND FILED SEPARATELY WITH THE COMMISSION PURSUANT TO A REQUEST FOR CONFIDENTIAL TREATMENT] | |||||||
[CONFIDENTIAL PORTION OMITTED AND FILED SEPARATELY WITH THE COMMISSION PURSUANT TO A REQUEST FOR CONFIDENTIAL TREATMENT] | |||||||
[CONFIDENTIAL PORTION OMITTED AND FILED SEPARATELY WITH THE COMMISSION PURSUANT TO A REQUEST FOR CONFIDENTIAL TREATMENT] |
6-1162-DME-1107
GAC Inc.
Page 1
1.3 “Commitment Limit” shall have the meaning set forth in Article 2, below.
1.4 [CONFIDENTIAL PORTION OMITTED AND FILED SEPARATELY WITH THE COMMISSION PURSUANT TO A REQUEST FOR CONFIDENTIAL TREATMENT]
1.5 [CONFIDENTIAL PORTION OMITTED AND FILED SEPARATELY WITH THE COMMISSION PURSUANT TO A REQUEST FOR CONFIDENTIAL TREATMENT]
2. Commitment.
[CONFIDENTIAL PORTION OMITTED AND FILED SEPARATELY WITH THE COMMISSION PURSUANT TO A REQUEST FOR CONFIDENTIAL TREATMENT]
3. Methods of Performance.
[CONFIDENTIAL PORTION OMITTED AND FILED SEPARATELY WITH THE COMMISSION PURSUANT TO A REQUEST FOR CONFIDENTIAL TREATMENT]
4. Commencement Date.
[CONFIDENTIAL PORTION OMITTED AND FILED SEPARATELY WITH THE COMMISSION PURSUANT TO A REQUEST FOR CONFIDENTIAL TREATMENT]
5. Project Approval.
[CONFIDENTIAL PORTION OMITTED AND FILED SEPARATELY WITH THE COMMISSION PURSUANT TO A REQUEST FOR CONFIDENTIAL TREATMENT]
GAC Inc | |
Letter Agreement No. 6-1162-DME-0824R2 | Page2 |
(d) [CONFIDENTIAL PORTION OMITTED AND FILED SEPARATELY WITH THE COMMISSION PURSUANT TO A REQUEST FOR CONFIDENTIAL TREATMENT].
(e) [CONFIDENTIAL PORTION OMITTED AND FILED SEPARATELY WITH THE COMMISSION PURSUANT TO A REQUEST FOR CONFIDENTIAL TREATMENT].
(f) [CONFIDENTIAL PORTION OMITTED AND FILED SEPARATELY WITH THE COMMISSION PURSUANT TO A REQUEST FOR CONFIDENTIAL TREATMENT]
[CONFIDENTIAL PORTION OMITTED AND FILED SEPARATELY WITH THE COMMISSION PURSUANT TO A REQUEST FOR CONFIDENTIAL TREATMENT].
2. [CONFIDENTIAL PORTION OMITTED AND FILED SEPARATELY WITH THE COMMISSION PURSUANT TO A REQUEST FOR CONFIDENTIAL TREATMENT]
(a) [CONFIDENTIAL PORTION OMITTED AND FILED SEPARATELY WITH THE COMMISSION PURSUANT TO A REQUEST FOR CONFIDENTIAL TREATMENT]
(b) [CONFIDENTIAL PORTION OMITTED AND FILED SEPARATELY WITH THE COMMISSION PURSUANT TO A REQUEST FOR CONFIDENTIAL TREATMENT]
(c) [CONFIDENTIAL PORTION OMITTED AND FILED SEPARATELY WITH THE COMMISSION PURSUANT TO A REQUEST FOR CONFIDENTIAL TREATMENT]
[CONFIDENTIAL PORTION OMITTED AND FILED SEPARATELY WITH THE COMMISSION PURSUANT TO A REQUEST FOR CONFIDENTIAL TREATMENT].
(d) [CONFIDENTIAL PORTION OMITTED AND FILED SEPARATELY WITH THE COMMISSION PURSUANT TO A REQUEST FOR CONFIDENTIAL TREATMENT].
(e) [CONFIDENTIAL PORTION OMITTED AND FILED SEPARATELY WITH THE COMMISSION PURSUANT TO A REQUEST FOR CONFIDENTIAL TREATMENT].
GAC Inc | |
Letter Agreement No. 6-1162-DME-0824R2 | Page3 |
[CONFIDENTIAL PORTION OMITTED AND FILED SEPARATELY WITH THE COMMISSION PURSUANT TO A REQUEST FOR CONFIDENTIAL TREATMENT].
3. Customer Support – Training
(a) [CONFIDENTIAL PORTION OMITTED AND FILED SEPARATELY WITH THE COMMISSION PURSUANT TO A REQUEST FOR CONFIDENTIAL TREATMENT].
(b) [CONFIDENTIAL PORTION OMITTED AND FILED SEPARATELY WITH THE COMMISSION PURSUANT TO A REQUEST FOR CONFIDENTIAL TREATMENT].
(c) [CONFIDENTIAL PORTION OMITTED AND FILED SEPARATELY WITH THE COMMISSION PURSUANT TO A REQUEST FOR CONFIDENTIAL TREATMENT].